BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 18043992)

  • 1. Comparison between metalloproteinases-2 and -9 in healthy subjects, diabetics, and subjects with acute coronary syndrome.
    Derosa G; D'Angelo A; Scalise F; Avanzini MA; Tinelli C; Peros E; Fogari E; Cicero AF
    Heart Vessels; 2007 Nov; 22(6):361-70. PubMed ID: 18043992
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metalloproteinase-2 and -9 in diabetic and nondiabetic subjects during acute coronary syndromes.
    Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Piccinni MN; Peros E; Geroldi D; Fogari E; D'Angelo A
    Endothelium; 2007; 14(1):45-51. PubMed ID: 17364896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects.
    Derosa G; D'Angelo A; Tinelli C; Devangelio E; Consoli A; Miccoli R; Penno G; Del Prato S; Paniga S; Cicero AF
    Diabetes Metab; 2007 Apr; 33(2):129-34. PubMed ID: 17320450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in combined dyslipidemia.
    Derosa G; Maffioli P; D'Angelo A; Salvadeo SA; Ferrari I; Fogari E; Gravina A; Mereu R; Palumbo I; Randazzo S; Cicero AF
    Clin Invest Med; 2009 Apr; 32(2):E124-32. PubMed ID: 19331801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metalloproteinases in diabetics and nondiabetics during acute coronary syndromes and after 3 months.
    Derosa G; Cicero AF; Scalise F; Avanzini MA; Tinelli C; Peros E; Fogari E; D'Angelo A
    Endothelium; 2007; 14(4-5):175-83. PubMed ID: 17922333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase-2 and -9 levels in obese patients.
    Derosa G; Ferrari I; D'Angelo A; Tinelli C; Salvadeo SA; Ciccarelli L; Piccinni MN; Gravina A; Ramondetti F; Maffioli P; Cicero AF
    Endothelium; 2008; 15(4):219-24. PubMed ID: 18663625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral blood levels of matrix and inflammatory mediators are elevated in Tunisian patients with acute coronary syndromes.
    Zayani Y; Allal-Elasmi M; Jacob MP; Zidi W; Zaroui A; Feki M; Mourali S; Mechmech R; Kaabachi N
    Clin Lab; 2013; 59(1-2):169-75. PubMed ID: 23505923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum matrix metalloproteinases MMP-2 and MMP-9 and metalloproteinase tissue inhibitors TIMP-1 and TIMP-2 in diabetic nephropathy.
    Rysz J; Banach M; Stolarek RA; Pasnik J; Cialkowska-Rysz A; Koktysz R; Piechota M; Baj Z
    J Nephrol; 2007; 20(4):444-52. PubMed ID: 17879211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The measurement of circulating matrix metalloproteinase-8 and its tissue inhibitor and their association with inflammatory mediators in patients with acute coronary syndrome.
    Allal-Elasmi M; Zayani Y; Zidi W; Zaroui A; Feki M; Mourali S; Mechmeche R; Kaabachi N
    Clin Lab; 2014; 60(6):951-6. PubMed ID: 25016699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in peripheral blood levels of TIMP-1, MMP-2, and MMP-9 in patients with type-2 diabetes.
    Lee SW; Song KE; Shin DS; Ahn SM; Ha ES; Kim DJ; Nam MS; Lee KW
    Diabetes Res Clin Pract; 2005 Aug; 69(2):175-9. PubMed ID: 16005367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of low-density lipoprotein apheresis on plasma matrix metalloproteinase-9 and serum tissue inhibitor of metalloproteinase-1 levels in diabetic hemodialysis patients with arteriosclerosis obliterans.
    Nakamura T; Matsuda T; Suzuki Y; Ueda Y; Koide H
    ASAIO J; 2003; 49(4):430-4. PubMed ID: 12918586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcription activity of MMP-2 and MMP-9 metalloproteinase genes and their tissue inhibitor (TIMP-2) in acute coronary syndrome patients.
    Dabek J; Glogowska-Ligus J; Szadorska B
    J Postgrad Med; 2013; 59(2):115-20. PubMed ID: 23793312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Matrix metalloproteinase-9 index as a possible parameter for predicting acute coronary syndrome in diabetics.
    Popović S; Canović F; Ilić M; Rafajlovski S; Dimitrijević-Srećović V; Matanović D; Vujović S; Djordjević P; Gostiljac D
    Vojnosanit Pregl; 2015 May; 72(5):421-6. PubMed ID: 26165049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Metalloproteinases MMP-2 and MMP-9 and their inhibitors TIMP-1 and TIMP-2 levels in children and adolescents with type 1 diabetes].
    Florys B; Głowińska B; Urban M; Peczyńska J
    Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(3):184-9. PubMed ID: 17020653
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome.
    Cheng M; Hashmi S; Mao X; Zeng QT
    Can J Cardiol; 2008 May; 24(5):385-90. PubMed ID: 18464944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gelatinases and their tissue inhibitors in a group of subjects with metabolic syndrome.
    Hopps E; Lo Presti R; Montana M; Noto D; Averna MR; Caimi G
    J Investig Med; 2013 Aug; 61(6):978-83. PubMed ID: 23661104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exercise ameliorates serum MMP-9 and TIMP-2 levels in patients with type 2 diabetes.
    Kadoglou NP; Vrabas IS; Sailer N; Kapelouzou A; Fotiadis G; Noussios G; Karayannacos PE; Angelopoulou N
    Diabetes Metab; 2010 Apr; 36(2):144-51. PubMed ID: 20149706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Matrix metalloproteinases 2 and 9 and their tissue inhibitors 1 and 2 in premenopausal obese women: relationship to cardiac function.
    Kosmala W; Plaksej R; Przewlocka-Kosmala M; Kuliczkowska-Plaksej J; Bednarek-Tupikowska G; Mazurek W
    Int J Obes (Lond); 2008 May; 32(5):763-71. PubMed ID: 18197181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease.
    Tayebjee MH; Lip GY; Tan KT; Patel JV; Hughes EA; MacFadyen RJ
    Am J Cardiol; 2005 Aug; 96(3):339-45. PubMed ID: 16054454
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Roles of matrix metalloproteinases, tissue inhibitor of matrix metalloproteinase and hs-CRP in Kawasaki disease].
    Chen R; Zhang AR; Zhao XX; Li ZH
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Dec; 11(12):989-91. PubMed ID: 20113606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.